ducovest

MUMC-B:CA:TSX-Manulife Multifactor U.S. Mid Cap Index ETF (CAD)

ETF | Others |

Last Closing

CAD 52.97

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

2.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

 CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

 CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

N/A

 CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

N/A

 CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

 CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

 CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

 CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

 CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

 CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

 CAD 2.68B

ETFs Containing MUMC-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.65% 79% B- 77% C+
Dividend Return 0.47% 9% A- 5% F
Total Return 24.11% 76% C+ 73% C
Trailing 12 Months  
Capital Gain 31.60% 81% B- 79% B-
Dividend Return 1.14% 14% F 10% F
Total Return 32.74% 80% B- 77% C+
Trailing 5 Years  
Capital Gain 69.34% 83% B 78% C+
Dividend Return 5.35% 12% F 8% B-
Total Return 74.69% 82% B 75% C
Average Annual (5 Year Horizon)  
Capital Gain 12.34% 89% A- 75% C
Dividend Return 12.38% 88% B+ 70% C-
Total Return 0.04% 30% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 15.66% 27% F 53% F
Risk Adjusted Return 79.03% 92% A 88% B+
Market Capitalization 0.05B 47% F 24% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.